Carmell Merger
Jul 14, 2023: Alpha Healthcare Acquisition Corp. III (Nasdaq: ALPA) (“ALPA”), a special purpose acquisition company led by Mr. Rajiv Shukla, today announced the successful closing of its definitive business combination agreement with Carmell Therapeutics, a Phase 2-stage biotechnology platform company developing allogeneic plasma-based biomaterials for bone and soft tissue healing indications.
ALPA IPO
July 26, 2021: Alpha Healthcare Acquisition Corp. III announced today that it priced its initial public offering of 15,000,000 units at $10.00 per unit. The units will be listed on the Nasdaq Capital Market and will begin trading on, July 27, 2021.